Bolt Biotherapeutics BOLT
NASDAQ BOLT
$3.45 -0.03 (-0.86%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bolt Biotherapeutics (BOLT) Cash from Investing Activities (2020 - 2026)

Updated

Bolt Biotherapeutics (BOLT) recorded Cash from Investing Activities of $7.77 million in Q2 2026, down 28.0% from $10.79 million a year earlier and down 1.9% from the prior quarter.

Analysis

Bolt Biotherapeutics (BOLT) Cash from Investing Activities (2020 - 2026) Analysis & Trends

On a TTM basis, Bolt Biotherapeutics' Cash from Investing Activities came in at $34.65 million as of Jun 30, 2026, down 36.7% year-over-year; for FY2025, it came in at $44.3 million, down 23.1% from FY2024.

  • Across earlier years, Cash from Investing Activities came in at $57.58 million in FY2024 (-19.0%), $71.04 million in FY2023 (+22.8%), $57.86 million in FY2022 and -$232.2 million in FY2021.
  • Quarterly Cash from Investing Activities has ranged from -$16.11 million in Q3 2021 to $40.85 million in Q1 2022 over the past five years.
  • On a year-over-year basis, Cash from Investing Activities has declined for three consecutive quarters, with an average decline of 18.1% over the last eight quarters.
  • Peak year-over-year performance for Cash from Investing Activities in the last five years was growth of 773.0% in Q3 2023, against a decline of 91.2% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $7.92 million (Q1 2026), $1.07 million (Q4 2025) and $17.88 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Bolt Biotherapeutics 6.65 Mn 6.65 Mn - 7.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.77 Mn
Mar 31, 2026 7.92 Mn
Dec 31, 2025 1.07 Mn
Sep 30, 2025 17.88 Mn
Jun 30, 2025 10.79 Mn
Mar 31, 2025 14.55 Mn
Dec 31, 2024 12.23 Mn
Sep 30, 2024 17.14 Mn
Jun 30, 2024 18.00 Mn
Mar 31, 2024 10.20 Mn
Dec 31, 2023 15.81 Mn
Sep 30, 2023 12.66 Mn
Jun 30, 2023 13.58 Mn
Mar 31, 2023 28.99 Mn
Dec 31, 2022 16.44 Mn
Sep 30, 2022 1.45 Mn
Jun 30, 2022 -868,000.00
Mar 31, 2022 40.85 Mn
Dec 31, 2021 21.03 Mn
Sep 30, 2021 -16.11 Mn
API Access

Bolt Biotherapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=BOLT&period=max&api_key=YOUR_API_KEY